NCT02137421View on ClinicalTrials.gov

A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

December 31, 2014

Conditions
Metabolic SyndromeCoronary Artery Disease
Interventions
DIETARY_SUPPLEMENT

Resveratrol (3, 4´, 5 trihydroxystilbene)

Resveratrol (RES) (3, 4´, 5 trihydroxystilbene)

Trial Locations (1)

Unknown

Islamic Republic of Iran, Tehran

All Listed Sponsors
lead

Tehran University of Medical Sciences

OTHER

NCT02137421 - A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter